Inhalerx Health Care
Biotech Cancer Healthcare Medical

$0.040 -0.008 (-16.67%)

High $0.04	Low $0.04	Trades 4	Turnover $6,750	Volume 172,500
30 June 2023 at 3:09pm

Market Cap (19-Sep) $6,895,205 (0th)	Close (30-Jun) $0.040 0 (0%)	Volume (30-Jun) 172,500	Shortsold (16-Jun) 5,714 (0.00%) (567th)
52w High $0.045	52w Low $0.017	P/E -	EPS -0.01

Short Interest

ASIC data, 16 Jun 2025

% Shorted

0.00% 0.00

vs 0.01% prior report

Most Shorted Rank

567th

of 709 shorted ASX stocks

Peak Short

0.01%

Aug 2023

Days to Cover

0.1

at 50d avg vol

View full short position history →

	Subject
	IRX IRX Ann: First Cohort Complete for Phase 1, Pain Indication IRX211
	1 (current) 2 3
	IRX IRX Ann: First Patient Dosed for Phase 1, Pain Indication IRX211
	IRX IRX Ann: Constitution
	IRX IRX Ann: Results of Meeting
	IRX IRX Ann: AGM Presentation
	IRX IRX Ann: Chairman's Address to Shareholders
	IRX IRX Ann: Quarterly Activities Report
	IRX IRX Ann: Quarterly Appendix 4C Cash Flow Report
	IRX IRX Ann: Notice of Annual General Meeting/Proxy Form
	IRX IRX Ann: Annual Report to shareholders
	IRX IRX Ann: Appendix 4G & Corporate Governance Statement
	IRX IRX Ann: Ethics Approval for Phase 1 CRPS
	IRX IRX Ann: Change in substantial holding
	IRX IRX Ann: Section 708A Notice
	IRX IRX Ann: Appendix 2A
	IRX IRX Ann: Preliminary Final Report
	IRX IRX Ann: Results of Meeting
	IRX IRX Ann: EGM Presentation
	IRX IRX Ann: Chairman's address
	IRX IRX Ann: Notification regarding unquoted securities - IRX
	IRX IRX Ann: Quarterly Activities Report
	IRX IRX Ann: Quarterly Appendix 4C Cash Flow Report
	IRX IRX Ann: Ceasing to be a substantial holder
	IRX IRX Ann: Notice of Extraordinary General Meeting/Proxy Form
	IRX IRX Ann: Contract Research Organisation Appointment
	IRX IRX Ann: Change of Director's Interest Notice
	IRX IRX Ann: Appendix 3G (Updated)
	IRX IRX Ann: Appendix 3G
	IRX IRX Ann: FDA Pre-IND Application Update
	IRX IRX Ann: Change in substantial holding
	IRX IRX Ann: Quarterly Activities Report
	IRX IRX Ann: Quarterly Appendix 4C Cash Flow Report
	IRX IRX Ann: Change in substantial holding
	IRX IRX Ann: Section 708A Notice
	IRX IRX Ann: Initial Director's Interest Notice
	IRX IRX Ann: Final Director's Interest Notice
	IRX IRX Ann: Appendix 2A
	IRX IRX Ann: Appendix 2A
	IRX IRX Ann: Appendix 3B (updated)
	IRX IRX Ann: Board and Management Changes
	IRX IRX Ann: Appendix 3B (updated)
	IRX IRX Ann: Appendix 3B (updated)
	IRX IRX Ann: Update to Share Placement
	IRX IRX Ann: Proposed issue of securities - IRX
	IRX IRX Ann: Proposed issue of securities - IRX
	IRX IRX Ann: Private Placement to raise $1.2m
	IRX IRX Ann: Trading Halt
	IRX IRX Ann: Half Yearly Report and Accounts
	IRX IRX Ann: Quarterly Activities Report
	IRX IRX Ann: Quarterly Appendix 4C Cash Flow Report

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.03	52,208	-0.01 (22.22%)
12-Sep	$0.04	25,650	0.00 (7.69%)
11-Sep	$0.04	0	+0.01 (18.18%)
05-Sep	$0.03	200,000	0.00 (5.71%)
04-Sep	$0.04	0	0.00 (0.00%)
03-Sep	$0.04	0	0.00 (0.00%)
29-Aug	$0.04	32,000	+0.00 (12.90%)
28-Aug	$0.03	67,027	0.00 (11.43%)
22-Aug	$0.04	75,000	0.00 (0.00%)
21-Aug	$0.04	125,000	0.00 (5.41%)
15-Aug	$0.04	0	0.00 (0.00%)
14-Aug	$0.04	4,300	0.00 (7.50%)
07-Aug	$0.04	32,705	0.00 (4.76%)
31-Jul	$0.04	23,809	0.00 (4.55%)
30-Jul	$0.04	0	0.00 (0.00%)
2 up, 8 down, and 5 flat days

Inhalerx Health Care
Biotech Cancer Healthcare Medical

Short Interest

Followers

Prices

Announcements

End of Day Prices

IRX Inhalerx Health Care Biotech Cancer Healthcare Medical

Short Interest

Followers

Prices

Announcements

End of Day Prices

Inhalerx Health Care
Biotech Cancer Healthcare Medical